CAS 1911578-99-8
:Remdesivir-001-LR
Description:
Remdesivir, identified by the CAS number 1911578-99-8, is an antiviral medication primarily developed for the treatment of viral infections, particularly those caused by RNA viruses such as the coronavirus responsible for COVID-19. It is a nucleotide analog that interferes with viral RNA replication, effectively inhibiting the virus's ability to multiply. The compound is administered intravenously and has shown efficacy in reducing the duration of symptoms in patients with severe COVID-19. Remdesivir is characterized by its ability to be phosphorylated within cells, leading to the incorporation of its active form into viral RNA, which ultimately results in premature termination of viral RNA synthesis. Its pharmacokinetics involve rapid distribution and metabolism, with a half-life that supports its therapeutic use. Common side effects may include nausea, elevated liver enzymes, and potential allergic reactions. Overall, Remdesivir represents a significant advancement in antiviral therapy, particularly in the context of emerging viral pandemics.
Formula:C21H23F5NO5P
Synonyms:- 2-Ethylbutyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate
- Remdesivir-001-LR
- 2-Ethylbutyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate Q: What is the CAS Number of
- L-Alanine, N-[(R)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 2-ethylbutyl ester
- 2-Ethylbutyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninateQ: What is
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
